A study of Microbiome-based therapy for the treatement of intrahepatic cholestasis of pregnancy.

Trial Profile

A study of Microbiome-based therapy for the treatement of intrahepatic cholestasis of pregnancy.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 19 Dec 2016

At a glance

  • Drugs Cholestasis-microbiome-based-therapy (Primary)
  • Indications Intrahepatic cholestasis
  • Focus Adverse reactions
  • Most Recent Events

    • 19 Dec 2016 New trial record
    • 08 Dec 2016 According to a Ferring Pharmaceuticals media release, the recruitment of patients for this study begun on 6 December 2016.
    • 05 Dec 2016 According to a Ferring Pharmaceuticals media release, recruitment of patients will begin on December 6, 2016 and will be conducted in cooperation with the Women's Clinic in Lund, Sweden.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top